<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">JS9</journal-id><journal-title-group><journal-title>International Journal of Surgery (London, England)</journal-title></journal-title-group><issn pub-type="ppub">1743-9191</issn><issn pub-type="epub">1743-9159</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430797</article-id><article-id pub-id-type="pmcid-ver">PMC12430797.1</article-id><article-id pub-id-type="pmcaid">12430797</article-id><article-id pub-id-type="pmcaiid">12430797</article-id><article-id pub-id-type="pmid">40844286</article-id><article-id pub-id-type="doi">10.1097/JS9.0000000000002661</article-id><article-id pub-id-type="publisher-id">IJS-D-25-02266</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Correspondence</subject></subj-group></article-categories><title-group><article-title>A commentary on &#8220;Oral microbiota as a biomarker for predicting the risk of malignancy in indeterminate pulmonary nodules: a prospective multicenter study&#8221;</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8169-7978</contrib-id><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zhaoxuan</given-names></name><degrees>MD</degrees><email>wang.zhaoxuan@outlook.com</email></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhao</surname><given-names initials="S">Shilei</given-names></name><degrees>MD</degrees><email>bbstnt@126.com</email></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Gu</surname><given-names initials="C">Chundong</given-names></name><degrees>MD</degrees><xref rid="COR0001" ref-type="corresp">*</xref></contrib><aff id="aff1">Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China</aff></contrib-group><author-notes><corresp id="COR0001"><label>*</label>Corresponding author. Address: Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China. Tel.: 0411-83635963-2061. E-mail: <email>guchundong@dmu.edu.cn</email> (C. Gu).</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>05</day><month>8</month><year>2025</year></pub-date><volume>111</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496813</issue-id><fpage>6512</fpage><lpage>6513</lpage><history><date date-type="received"><day>12</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>27</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/">Creative Commons Attribution-NonCommercial-ShareAlike 4.0</ext-link> License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="js9-111-6512.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js9-111-6512.pdf"/><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>
<italic toggle="yes">Dear Editor,</italic>
</p><p>We read with great interest the recent multicenter study by Ma <italic toggle="yes">et al</italic><sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> on the use of oral microbiota profiling to predict malignancy in indeterminate pulmonary nodules (IPNs). In a prospective cohort of 1040 IPN patients across three centers, they successfully collected saliva, throat swab, and tongue-coating samples from 460 IPN patients and 70 healthy controls, applying 16S rRNA sequencing coupled with seven machine learning (ML) models to identify predictive microbial signatures. This integrated strategy, combining high-throughput sequencing, fluorescence <italic toggle="yes">in situ</italic> hybridization validation, and a visualized IPN risk prediction system, is a novel strength of the study. As recommended by the Transparency In The reporting of Artificial Intelligence (TITAN) guideline 2025<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup>, we ensure the article is compliant with the guideline and respectfully propose the following points for further consideration and potential enhancement of future work.</p><p>First, the study offers robust statistical power. Prospectively enrolling and following patients addresses potential selection biases, thereby enhancing the internal validity and clinical relevance of the findings. By comparing saliva, tongue, and throat samples, the authors systematically identified saliva as the optimal site for IPN prediction. This comparison of niches represents a clear advance over prior studies, which typically focused on a single sample type. Then, the use of fluorescence <italic toggle="yes">in situ</italic> hybridization to visualize bacteria within tumor tissue provides confirmation that microbes identified in oral samples are present in lung lesions. In addition, testing the identified biomarkers against independent external cohorts (e.g., other lung cancer and non-lung disease datasets) strengthens the specificity and generalizability of the findings. Seven ML models (support vector machine, logistic regression, naive Bayes, multi-layer perceptron, random forest, gradient-boosting decision tree, and LightGBM) were trained and compared, ensuring optimal model selection. Notably, the authors used SHAP (Shapley Additive exPlanations) to interpret the saliva-LightGBM model, highlighting which core taxa drive the prediction. This transparency is a friendly methodological asset in a clinical context.</p><p>Second, the clinical relevance of this work is important. Differentiating malignant from benign IPNs is a major challenge in thoracic surgery. Current tools (e.g., radiographic models) have limited sensitivity and often lead to invasive biopsy or resection with attendant risks. A saliva-based test could serve as a safer, noninvasive &#8220;liquid biopsy&#8221; to augment decision-making. Saliva-LightGBM model achieved high discriminative performance (area under the curve [AUC] = 0.887, 95% confidence interval [CI]: 0.865&#8211;0.918) and identified biologically plausible oral genera (<italic toggle="yes">Actinomyces, Rothia, Streptococcus, Prevotella, Porphyromonas</italic>, and <italic toggle="yes">Veillonella</italic>) as malignant predictors. By stratifying IPN malignancy risk before any invasive procedure, such a tool could help avoid unnecessary surgeries or delays.</p><p>Third, these findings build upon and substantially support current understandings of microbiota-driven oncogenic mechanisms in lung cancer. Yang <italic toggle="yes">et al</italic><sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> reported dysbiosis of salivary bacteria in non-smoking women with lung cancer, revealing <italic toggle="yes">Sphingomonas</italic> and <italic toggle="yes">Blastomonas</italic> positively correlated with immunocytochemistry markers (CK7 and Napsin A) and functional enrichment in p53 signaling pathway, pathways in cancer, apoptosis, and tuberculosis. Additionally, Zhou <italic toggle="yes">et al</italic><sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> found that periodontal pathogens, including <italic toggle="yes">Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans</italic>, and <italic toggle="yes">Porphyromonas gingivalis,</italic> correlate with lung cancer risk in the atherosclerosis risk in communities study. Besides, a recent study<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> also showed that specific principal component vectors of microbial communities and increased <italic toggle="yes">Streptococcus</italic> abundance were associated with lung cancer risk. However, Ma <italic toggle="yes">et al</italic>&#8217;s study is distinct in its design: no prior study has compared multiple oral sample types in a large IPN cohort or rigorously integrated explainable ML. The present study thus represents a significant advance in the field. The systematic approach and confirmatory analyses give confidence that the identified taxa are reproducible biomarkers, rather than chance associations.</p><p>Finally, we congratulate the authors on this comprehensive study and offer a few suggestions for further work. Applying the saliva-based model in independent, pre-operative IPN cohorts (e.g., in a clinical trial or pre-surgical assessment setting) would confirm its real-world utility. Combining microbiota profiles with radiomic features from CT scans or with pathomics might yield even higher accuracy. A unified model leveraging oral microbial, imaging, and histopathologic data could be highly powerful. Tracking microbiota changes over time in IPN patients may reveal how microbial shifts relate to nodule progression. Functional studies could elucidate mechanisms behind the associations.</p><p>In summary, Ma <italic toggle="yes">et al</italic> provide a compelling proof-of-concept that oral microbiota profiling can noninvasively stratify IPN malignancy risk. This work paves the way for integrating microbiome diagnostics into lung cancer screening algorithms. We look forward to further validation and clinical translation of these findings.</p></body><back><ack><title>Acknowledgements</title><p>None.</p></ack><fn-group><fn fn-type="other"><p>Z.W. and S.Z. contributed equally to the manuscript.</p></fn><fn fn-type="other"><p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p></fn><fn fn-type="equal"><p>Published online 5 August 2025</p></fn></fn-group><sec><title>Ethical approval</title><p>Not applicable.</p></sec><sec><title>Consent</title><p>Not applicable.</p></sec><sec><title>Sources of funding</title><p>All the authors declare to have received no financial support or sponsorship for this study.</p></sec><sec><title>Author contributions</title><p>Z.W.: conceptualization, writing &#8211; original draft, writing &#8211; review &amp; editing. S.Z.: writing &#8211; review &amp; editing. C.G.: writing &#8211;review &amp; editing.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest disclosure</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Research registration unique identifying number (UIN)</title><p>Not applicable.</p></sec><sec><title>Guarantor</title><p>Chundong Gu.</p></sec><sec><title>Provenance and peer review</title><p>Commentary, internally reviewed.</p></sec><sec sec-type="data-availability"><title>Data availability statement</title><p>Not applicable.</p></sec><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>Q</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CX</given-names></name><name name-style="western"><surname>He</surname><given-names>JW</given-names></name><etal/></person-group>. <article-title>Oral microbiota as a biomarker for predicting the risk of malignancy in indeterminate pulmonary nodules: a prospective multicenter study</article-title>. <source>Int J Surg</source><year>2025</year>;<volume>111</volume>:<fpage>2055&#8211;71</fpage>.<pub-id pub-id-type="pmid">39728732</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JS9.0000000000002152</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agha</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mathew</surname><given-names>G</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Transparency in the reporting of artificial intelligence &#8211; the TITAN guideline</article-title>. <source>Prem J Sci</source><year>2025</year>;<volume>10</volume>:<fpage>100082</fpage>.</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Mu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Dysbiosis of the salivary microbiome is associated with non-smoking female lung cancer and correlated with immunocytochemistry markers</article-title>. <source>Front Oncol</source><year>2018</year>;<volume>8</volume>:<fpage>520</fpage>.<pub-id pub-id-type="pmid">30524957</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2018.00520</pub-id><pub-id pub-id-type="pmcid">PMC6256243</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>B</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Beck</surname><given-names>JD</given-names></name><etal/></person-group>. <article-title>Periodontal and other oral bacteria and risk of lung cancer in the atherosclerosis risk in communities (ARIC) study</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source><year>2023</year>;<volume>32</volume>:<fpage>505&#8211;15</fpage>.<pub-id pub-id-type="pmid">35999656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1055-9965.EPI-22-0601</pub-id><pub-id pub-id-type="pmcid">PMC9947191</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogtmann</surname><given-names>E</given-names></name><name name-style="western"><surname>Hua</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>The oral microbiome and lung cancer risk: an analysis of 3 prospective cohort studies</article-title>. <source>J National Cancer Inst</source><year>2022</year>;<volume>114</volume>:<fpage>1501&#8211;10</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djac149</pub-id><pub-id pub-id-type="pmcid">PMC9664178</pub-id><pub-id pub-id-type="pmid">35929779</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>